Lumavita's Series A - II Round

Lumavita raised a round of funding on June 16, 2009.

Lumavita AG is a biopharmaceutical company focusing on novel anti-infectives for women's health. The Company's product portfolio includes FemiFect (pentamycin) a polyene macrolide with a unique spect…

Articles about Lumavita's Series A - II Round: